403
Participants
Start Date
November 4, 2016
Primary Completion Date
October 16, 2019
Study Completion Date
October 28, 2019
Pimavanserin
Pimavanserin 34 mg, 20 mg, or 10 mg, taken as two tablets, once daily by mouth
Placebo
Placebo, taken as two tablets, once daily by mouth
Budapest
Budapest
Budapest
Budapest
Sofia
Sofia
Sofia
Sofia
Plovdiv
Debrecen
Tserova Koria
Gyula
Kalocsa
Pécs
Targovishte
Varna
Prague
Prague
Belgrade
Rochester
Prague
Downingtown
Smila
Vinnytsia
Říčany
Kovin
Durham
Madrid
Charlotte
Charleston
Decatur
Marietta
Atlanta
Atlanta
Pilsen
Oviedo
Hialeah
Miami
Miami
Lauderhill
Tampa
Poltava
Valladolid
Ann Arbor
Dnipro
Zamora
Hradec Králové
Hoffman Estates
Chicago
Kharkiv
Odesa
Wichita
Oleksandrivka
Rogers
Oklahoma City
Kherson
Irving
Richardson
Lviv
Lviv
Phoenix
Albuquerque
Las Vegas
Torrance
Norwalk
Bellflower
Lemon Grove
San Diego
San Diego
Santa Ana
Yaroslavl
Roshchino
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Smolensk
Stavropol
Plekhanovo
Samara
Yekaterinburg
Berlin
Penticton
Chatham
Montreal
Toronto
Bialystok
Bydgoszcz
Lublin
Lublin
Pruszcz Gdański
Belgrade
Kovin
Kragujevac
Niš
Barcelona
Hlevakha
Kyiv
Kyiv
Kyiv
Kyiv
Lead Sponsor
ACADIA Pharmaceuticals Inc.
INDUSTRY